Have a feature idea you'd love to see implemented? Let us know!

TGTX Tg Therapeutics PE ratio, current and historical analysis

The current price-to-earnings ratio of TGTX can't be determined, as the TTM EPS of -$0.09 is negative. The last PE ratio of Tg Therapeutics, recorded in June 2024, was 26.16.

TGTX PE ratio history

How has TGTX's PE ratio performed in the past

Average

N/A

Median

N/A

Minimum

N/A

Maximum

N/A

Tg Therapeutics PE ratio by year

Year	PE ratio	Change
2023	189.78	N/A
2022	N/A	N/A
2021	N/A	N/A
2020	N/A	N/A
2019	N/A	N/A
2018	N/A	N/A
2017	N/A	N/A
2016	N/A	N/A
2015	N/A	N/A
2014	N/A	N/A

TGTX average PE ratio chart

What is the average PE ratio of TGTX for the past years

3-year avg

N/A

5-year avg

N/A

10-year avg

N/A

15-year avg

N/A

TGTX PE vs peers

What is TGTX's PE ratio compared to its peers

Stock name	PE ratio	Market cap
ALKS Alkermes plc	13.78	$4.48B
NERV Minerva Neurosciences Inc	N/A	$15.46M
TGTX Tg Therapeutics Inc	N/A	$5.38B

Frequently asked questions

What is Tg Therapeutics's PE ratio?

The current price to earnings ratio of TGTX can't be calculated, as its EPS of -$0.09 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.